Methyl-MMDA-2

From Self-sufficiency
Revision as of 16:08, 17 August 2010 by Nirmos (Talk) (Removed two redundant categories.)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Methyl-MMDA-2
File:Methyl-MMDA-2-structure.png
Systematic (IUPAC) name
N-methyl-1-(6-methoxy-1,3-benzodioxol-5-yl)propan-2-amine
Clinical data
Routes of
administration
Oral, Insufflated, Rectal
Legal status
Legal status
Identifiers
CAS Number ?
ATC code none
PubChem CID ?
ChemSpider 23553107
Chemical data
Formula C12H17NO3
Molar mass 223.27 g/mol[[Script error: No such module "String".]]
Script error: No such module "collapsible list".
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

N-Methyl-2-methoxy-4,5-methylenedioxyamphetamine (Methyl-MMDA-2; 6-Methoxy-MDMA) is a psychedelic drug of the amphetamine class.[1] It is the N-methylated derivative of MMDA-2, and is also an analogue of MDMA and 6-methyl-MDA.[1]

Methyl-MMDA-2 was first synthesized by Alexander Shulgin and was described in his book PiHKAL. He states that it is essentially inactive at a dose of 70 mg, and he did not try any higher;[1] however, Methyl-MMDA-2 is still likely to be active, perhaps in the 125-250 mg range.[citation needed] This reduction in hallucinogenic activity relative to MMDA-2 parallels that of MDA and MDMA, indicating that with phenethylamines, N-methylation substantially reduces 5-HT2A receptor affinity.[1][2]

See also

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />

External links

  1. 1.0 1.1 1.2 1.3 Ann Shulgin; Alexander Shulgin (1991). Pihkal: A Chemical Love Story. Transform Press. ISBN 0-9630096-0-5. 
  2. Nichols DE, Oberlender R (1989). "Structure-activity relationships of MDMA-like substances". NIDA Research Monograph. 94: 1–29. PMID 2575223.